VERA (STOCKS)
Vera Therapeutics, Inc. Class A Common Stock
$34.240000
-0.020000 (-0.06%)
Prev close: $34.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Marshall W. Fordyce
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,458.56M
- Employees
- 224
- P/E (TTM)
- -6.17
- P/B (TTM)
- 4.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.69 | $-1.35 | -0.3365 | -24.86% |
|
Dec 2025 (Q4)
|
$-1.39 | $-1.31 | -0.0827 | -6.33% |
|
Sep 2025 (Q3)
|
$-1.26 | $-1.16 | -0.1015 | -8.76% |
|
Jun 2025 (Q2)
|
$-1.20 | $-0.84 | -0.3619 | -43.18% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $14.46M |
| Operating Expenses | $383.41M |
| Research and Development | $259.99M |
| Other Operating Expenses | $123.42M |
| Operating Income/Loss | -$383.41M |
| Income/Loss From Continuing Operations After Tax | -$368.95M |
| Income/Loss From Continuing Operations Before Tax | -$368.95M |
| Net Income/Loss | -$368.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$368.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$368.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.54 |
| Diluted Earnings Per Share | -$5.54 |
| Basic Average Shares | 199,576,819 |
| Diluted Average Shares | 199,576,819 |
| Assets | $621.74M |
| Current Assets | $615.80M |
| Noncurrent Assets | $5.94M |
| Fixed Assets | $945.00K |
| Other Non-current Assets | $4.99M |
| Liabilities | $122.04M |
| Current Liabilities | $45.15M |
| Accounts Payable | $13.91M |
| Wages | $6.34M |
| Other Current Liabilities | $24.90M |
| Noncurrent Liabilities | $76.89M |
| Long-term Debt | $75.03M |
| Other Non-current Liabilities | $1.86M |
| Equity | $499.70M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $499.70M |
| Liabilities And Equity | $621.74M |
| Net Cash Flow From Operating Activities | -$293.20M |
| Net Cash Flow From Operating Activities, Continuing | -$293.20M |
| Net Cash Flow From Investing Activities | $41.15M |
| Net Cash Flow From Investing Activities, Continuing | $41.15M |
| Net Cash Flow From Financing Activities | $311.31M |
| Net Cash Flow From Financing Activities, Continuing | $311.31M |
| Net Cash Flow | $59.26M |
| Net Cash Flow, Continuing | $59.26M |
| Comprehensive Income/Loss | -$369.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$369.64M |
| Other Comprehensive Income/Loss | -$293.11M |